Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lerche (Leipzig , Germany), A. Frille (Leipzig, Germany), H. Wirtz (Leipzig, Germany), J. Wiegand (Leipzig, Germany), V. Keim (Leipzig, Germany), T. Karlas (Leipzig, Germany), S. Tegelkamp (Leipzig, Germany), H. Seyfarth (Leipzig, Germany). Cirrhose cardiaque in pulmonary hypertension- a case series.. 3094

Member's Comments

No comment yet.

Related content which might interest you: Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care Source: International Congress 2017 – French Programme 2017 Year: 2017 Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done? Source: Virtual Congress 2021 – French programme 2021 Year: 2021 Does emphysema influence the application of du Bois score in idiopathic pulmonary fibrosis? Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Diagnostic de l’EP chez la femme enceinte / Diagnosis of pulmonary embolism in pregnant women Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020 Tt anti fibrotiques hors FPI: approche raisonnée / Anti-fibrotic treatments for conditions other than idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last ! Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020 Recommandations européennes ERS/ESC pour le diagnostic et la prise en charge de l’hypertension pulmonaireERS/ESC European guidelines for the diagnosis and treatment of pulmonary hypertension Source: International Congress 2016 – ERS/French Programme II Year: 2016 Réduction volumique par spirales dans le traitement de l’emphysème sévèreLung reduction coil treatment in severe emphysema Source: International Congress 2016 – ERS/French Programme I Year: 2016 Surgical management of pulmonary aspergillome: about 84 cases Source: International Congress 2019 – General thoracic surgery Year: 2019 La thermoplastie dans l’asthme : corrélation clinique et histopathologiqueAsthma thermoplasty: clinical and histopathological correlation Source: International Congress 2017 – French Programme 2017 Year: 2017 Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020 Nuevos tratamientos para la fibrosis pulmonar Source: Annual Congress 2013 –Sesión conjunta en castellano organizada por la SEPAR (España) y la ALAT (Latinamérica) Year: 2013 La diffusion pulmonaire du monoxyde d’azote (DLNO): des recommandations pratiques aux applications cliniquesLung transfer of Nitric Oxide (DLNO): from practical guidelines to clinical applications Source: International Congress 2016 – ERS/French Programme II Year: 2016 Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment Source: International Congress 2016 – ERS/French Programme I Year: 2016 Etiology of interstitial lung disease in children: case serie reports in Morocco Source: Eur Respir J 2004; 24: Suppl. 48, 394s Year: 2004 Exploration de la fonction respiratoire selon l'âge / Lung function testing and age Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020 The endothelin system in pulmonary and renal vasculopathy: les liaisons dangereuses Source: Eur Respir Rev 2009; 18: 260-271 Year: 2009